ranibizumab (lucentis) Report issue

Biologics mAb Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

VA Big4

$746.5400 - $1310.6600

AUS PBS

$764.8645

VA FSS

$1170.0000 - $1950.0000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ranibizumab 10 mg / 1 mL (1 mL INJECTION) $1233.4700 VA Big4
  • LUCENTIS (1)
    		•  Genentech USA
    ranibizumab 10 mg / 1 mL (1 mL INJECTION) $1310.6600 VA Big4
  • LUCENTIS (1)
    		•  Genentech USA
    ranibizumab 10 mg / 1 mL (1 mL INJECTION) $1950.0000 VA FSS
  • LUCENTIS (1)
    		•  Genentech USA
  • LUCENTIS (1)
    		•  Genentech USA
    ranibizumab 1.65 mg / 0.165 mL (INJECTION) $764.8645 AUS PBS generic
  • Lucentis (1)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    ranibizumab 2.3 mg / 0.23 mL (INJECTION) $764.8645 AUS PBS generic
  • Lucentis (1)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    ranibizumab 6 mg / 1 mL (1 mL INJECTION) $746.5400 VA Big4
  • LUCENTIS (1)
    		•  Genentech USA
    ranibizumab 6 mg / 1 mL (1 mL INJECTION) $783.3100 VA Big4
  • LUCENTIS (1)
    		•  Genentech USA
    ranibizumab 6 mg / 1 mL (1 mL INJECTION) $1170.0000 VA FSS
  • LUCENTIS (1)
    		•  Genentech USA
  • LUCENTIS (1)
    		•  Genentech USA

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue